BRCA Mutation clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Sorry, in progress, not accepting new patients
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy.
Los Angeles 5368361, California 5332921 and other locations
Last updated: